Advertisement
BMRN vs CLNN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and CLNN is a StrongBuy.
BMRN's RSI Indicator ascends from oversold territory
The RSI Oscillator for BMRN moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 20 of the 30 cases the stock moved higher. This puts the odds of a move higher at 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for BMRN just turned positive on October 20, 2026. Looking at past instances where BMRN's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.
Following a +4.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRN advanced for three days, in 162 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMRN as a result. In 64 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
BMRN broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BMRN entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. BMRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.716) is normal, around the industry mean (3.498). BMRN's P/E Ratio (151.432) is considerably higher than the industry average of (-1.193). Projected Growth (PEG Ratio) (0.348) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (3.727) is also within normal values, averaging (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for CLNN turns positive, indicating new upward trend
CLNN saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 78 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLNN's RSI Indicator exited the oversold zone, 38 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for CLNN just turned positive on October 21, 2026. Looking at past instances where CLNN's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
CLNN moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CLNN crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +11.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLNN advanced for three days, in 191 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 105 of 124 cases where CLNN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 48 cases where CLNN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLNN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
CLNN broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. CLNN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.266) is normal, around the industry mean (6.914). P/E Ratio (-1.113) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. CLNN's P/S Ratio (222.222) is very high in comparison to the industry average of (5.003).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLNN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
BMRN | CLNN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 100 | |
PRICE GROWTH RATING 1..100 | 55 | 61 | |
P/E GROWTH RATING 1..100 | 2 | 14 | |
SEASONALITY SCORE 1..100 | 75 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLNN's Valuation (95) in the null industry is in the same range as BMRN (98) in the Biotechnology industry. This means that CLNN’s stock grew similarly to BMRN’s over the last 12 months.
CLNN's Profit vs Risk Rating (100) in the null industry is in the same range as BMRN (100) in the Biotechnology industry. This means that CLNN’s stock grew similarly to BMRN’s over the last 12 months.
BMRN's SMR Rating (89) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.
BMRN's Price Growth Rating (55) in the Biotechnology industry is in the same range as CLNN (61) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.
BMRN's P/E Growth Rating (2) in the Biotechnology industry is in the same range as CLNN (14) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.
| BMRN | CLNN | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 86% |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 57% | 2 days ago 83% |
| Advances ODDS (%) | 16 days ago 58% | 5 days ago 83% |
| Declines ODDS (%) | 9 days ago 62% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMRN’s FA Score shows that 1 FA rating(s) are green while CLNN’s FA Score has 1 green FA rating(s).
- BMRN’s FA Score: 1 green, 4 red.
- CLNN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMRN’s TA Score shows that 3 TA indicator(s) are bullish while CLNN’s TA Score has 7 bullish TA indicator(s).
- BMRN’s TA Score: 3 bullish, 5 bearish.
- CLNN’s TA Score: 7 bullish, 3 bearish.
Price Growth
BMRN (@Biotechnology) experienced а +2.14% price change this week, while CLNN (@Food: Major Diversified) price change was -0.76% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -18.27%.
The average weekly price growth across all stocks in the @Food: Major Diversified industry was +1.76%. For the same industry, the average monthly price growth was -4.67%, and the average quarterly price growth was -16.15%.
Reported Earning Dates
BMRN is expected to report earnings on Feb 24, 2027.
CLNN is expected to report earnings on Mar 29, 2027.
Industries' Descriptions
@Biotechnology (-3.38% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Food: Major Diversified (+1.76% weekly)Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.
Advertisement
CLNN and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLNN has been loosely correlated with KYMR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CLNN jumps, then KYMR could also see price increases.
| Ticker / NAME | Correlation To CLNN | 1D Price Change % | ||
|---|---|---|---|---|
| CLNN | 100% | -2.00% | ||
| KYMR - CLNN | 36% Loosely correlated | +0.31% | ||
| VERA - CLNN | 35% Loosely correlated | -3.24% | ||
| KZIA - CLNN | 33% Poorly correlated | -4.75% | ||
| GOSS - CLNN | 30% Poorly correlated | -2.40% | ||
| BMRN - CLNN | 30% Poorly correlated | +0.93% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BHDG | 24.71 | 0.66 | +2.73% |
| Nicholas Bitcoin Tail ETF (BHDG) | |||
| IBDZ | 24.75 | -0.01 | -0.04% |
| iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) | |||
| BFOR | 23.19 | -0.06 | -0.26% |
| ALPS Barron's 400 ETF (BFOR) | |||
| IBIT | 38.94 | -1.42 | -3.52% |
| iShares Bitcoin Trust ETF (IBIT) | |||
| COHX | 10.67 | -1.45 | -11.96% |
| Tradr 2X Long COHR Daily ETF (COHX) | |||